{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:52:19Z","timestamp":1793803939745,"version":"4.6.1"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejphar.2024.176929","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T23:40:47Z","timestamp":1724370047000},"page":"176929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Vortioxetine ameliorates experimental autoimmune encephalomyelitis model of multiple sclerosis in mice via activation of PI3K\/Akt\/CREB\/BDNF cascade and modulation of serotonergic pathway signaling"],"prefix":"10.1016","volume":"982","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1263-4541","authenticated-orcid":false,"given":"Marwa S.","family":"Shafiek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa Y.","family":"Mekky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha N.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed F.","family":"El-Yamany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9488-2320","authenticated-orcid":false,"given":"Mostafa A.","family":"Rabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176929_bib1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1046\/j.1471-4159.1999.721489.x","article-title":"Agonist stimulation of the serotonin 1A receptor causes suppression of anoxia\u2010induced apoptosis via mitogen\u2010activated protein kinase in neuronal HN2\u20105 cells","volume":"72","author":"Adayev","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2024.176929_bib2","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1098\/rstb.2012.0190","article-title":"The neurobiology of depression\u2014revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms","volume":"367","author":"Albert","year":"2012","journal-title":"Phil. Trans. Biol. Sci."},{"key":"10.1016\/j.ejphar.2024.176929_bib3","first-page":"25","article-title":"[A chronic fatigue syndrome and blood platelet serotonin levels in patients with multiple sclerosis]","volume":"114","author":"Ba\u012ddina","year":"2014","journal-title":"Zh Nevrol Psikhiatr Im S I\u2019m Korsakova"},{"key":"10.1016\/j.ejphar.2024.176929_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.17116\/jnevro201811808277","article-title":"Interferon-induced depression and peripheral blood serotonin in patients with multiple sclerosis","volume":"118","author":"Baidina","year":"2018","journal-title":"Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"},{"key":"10.1016\/j.ejphar.2024.176929_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/0269881116628440","article-title":"The safety and tolerability of vortioxetine: analysis of data from randomized placebo-controlled trials and open-label extension studies","volume":"30","author":"Baldwin","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib6","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"6","author":"Bathina","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ejphar.2024.176929_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/1381612822666161214153108","article-title":"Multiple sclerosis and neuroinflammation: the overview of current and prospective therapies","volume":"23","author":"Bjelobaba","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2024.176929_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.176929_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/1352458518805246","article-title":"Animal models of multiple sclerosis: from rodents to zebrafish","volume":"25","author":"Burrows","year":"2019","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.ejphar.2024.176929_bib10","doi-asserted-by":"crossref","DOI":"10.3791\/3638","article-title":"The mouse forced swim test","author":"Can","year":"2011","journal-title":"JoVE"},{"key":"10.1016\/j.ejphar.2024.176929_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.809541","article-title":"Antioxidant activity of fluoxetine and vortioxetine in a non-transgenic animal model of Alzheimer's disease","volume":"12","author":"Caruso","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00021","article-title":"Neuroprotective role of the PI3 kinase\/akt signaling pathway in zebrafish","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2024.176929_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.mcn.2007.08.004","article-title":"Serotonin stimulates mitochondrial transport in hippocampal neurons","volume":"36","author":"Chen","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176929_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.pharep.2017.01.011","article-title":"Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents","volume":"69","author":"Chilmonczyk","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2024.176929_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00063030-200519050-00003","article-title":"Mechanisms of action for treatments in multiple sclerosis: does a heterogeneous disease demand a multi-targeted therapeutic approach?","volume":"19","author":"Chofflon","year":"2005","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejphar.2024.176929_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2217\/fnl.12.72","article-title":"A critical kinase cascade in neurological disorders: PI3K, Akt and mTOR","volume":"7","author":"Chong","year":"2012","journal-title":"Future Neurol."},{"key":"10.1016\/j.ejphar.2024.176929_bib17","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/0269881118788826","article-title":"Efficacy of vortioxetine on the physical symptoms of major depressive disorder","volume":"32","author":"Christensen","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577480","article-title":"Modulation of the HMGB1\/TLR4\/NF-\u03baB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis","volume":"352","author":"Chu","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2024.176929_bib19","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2024.176929_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib21","author":"Corscadden"},{"key":"10.1016\/j.ejphar.2024.176929_bib22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1471-4159.2005.03107.x","article-title":"5\u2010HT 1A receptors couple to activation of Akt, but not extracellular\u2010regulated kinase (ERK), in cultured hippocampal neurons","volume":"93","author":"Cowen","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2024.176929_bib23","series-title":"Handbook of Histopathological and Histochemical Techniques: Including Museum Techniques","author":"Culling","year":"2013"},{"key":"10.1016\/j.ejphar.2024.176929_bib24","first-page":"36","article-title":"Vortioxetine (brintellix): a new serotonergic antidepressant","volume":"40","author":"D'Agostino","year":"2015","journal-title":"P T"},{"key":"10.1016\/j.ejphar.2024.176929_bib25","article-title":"A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase","volume":"431","author":"Davies","year":"2011","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.ejphar.2024.176929_bib26","series-title":"Multiple Sclerosis","first-page":"249","article-title":"Pathophysiology of experimental autoimmune encephalomyelitis","author":"Denic","year":"2016"},{"key":"10.1016\/j.ejphar.2024.176929_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.devbrainres.2005.06.015","article-title":"Signaling pathways involved with serotonin1A agonist-mediated neuroprotection against ethanol-induced apoptosis of fetal rhombencephalic neurons","volume":"159","author":"Druse","year":"2005","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176929_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119865","article-title":"Vortioxetine mitigates neuronal damage by restricting PERK\/eIF2\u03b1\/ATF4\/CHOP signaling pathway in rats subjected to focal cerebral ischemia-reperfusion","volume":"283","author":"Emam","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2024.176929_bib29","series-title":"White Matter Diseases","first-page":"1","article-title":"Multiple sclerosis","author":"Filippi","year":"2020"},{"key":"10.1016\/j.ejphar.2024.176929_bib30","article-title":"Multiple sclerosis: overview of disease-modifying agents","volume":"6","author":"Finkelsztejn","year":"2014","journal-title":"Perspect. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176929_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuint.2019.04.006","article-title":"Exendin-4 attenuates brain mitochondrial toxicity through PI3K\/Akt-dependent pathway in amyloid beta (1\u201342)-induced cognitive deficit rats","volume":"128","author":"Garabadu","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2024.176929_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","article-title":"Target regulation of PI3K\/Akt\/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis","volume":"116","author":"Giacoppo","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejphar.2024.176929_bib33","doi-asserted-by":"crossref","first-page":"a028977","DOI":"10.1101\/cshperspect.a028977","article-title":"Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS)","volume":"8","author":"Glatigny","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ejphar.2024.176929_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/17460441.2019.1546691","article-title":"Vortioxetine: a novel antidepressant for the treatment of major depressive disorder","volume":"14","author":"Gonda","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.176929_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2023.1122381","article-title":"Multiple modulatory roles of serotonin in chronic pain and injury-related anxiety","volume":"15","author":"Hao","year":"2023","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.ejphar.2024.176929_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneumeth.2017.04.003","article-title":"Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL\/6 mice for the longitudinal study of pathology and repair","volume":"284","author":"Hasselmann","year":"2017","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2024.176929_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-\u03baB by TNF family cytokines","volume":"26","author":"Hayden","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ejphar.2024.176929_bib38","doi-asserted-by":"crossref","first-page":"a011189","DOI":"10.1101\/cshperspect.a011189","article-title":"PI3K-PKB\/Akt pathway","volume":"4","author":"Hemmings","year":"2012","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejphar.2024.176929_bib39","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","article-title":"The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration","volume":"26","author":"Heras-Sandoval","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2024.176929_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2017.00048","article-title":"The effects of serotonin in immune cells","volume":"4","author":"Herr","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ejphar.2024.176929_bib41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00259-013-2636-z","article-title":"Altered serotonin transporter availability in patients with multiple sclerosis","volume":"41","author":"Hesse","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejphar.2024.176929_bib42","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1111\/j.1460-9568.2006.04859.x","article-title":"Signalling mechanisms mediated by the phosphoinositide 3\u2010kinase\/Akt cascade in synaptic plasticity and memory in the rat","volume":"23","author":"Horwood","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176929_bib43","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.3892\/etm.2017.4410","article-title":"Multiple sclerosis: pathology, diagnosis and treatments","volume":"13","author":"Huang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2024.176929_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnen\/61.2.142","article-title":"Effects of brain-derived neurotrophic factor (BDNF) on compression-induced spinal cord injury: BDNF attenuates down-regulation of superoxide dismutase expression and promotes up-regulation of myelin basic protein expression","volume":"61","author":"Ikeda","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.176929_bib45","series-title":"Multiple Sclerosis: A Mechanistic View","first-page":"1","article-title":"Clinical manifestations of multiple sclerosis: an overview","author":"Javalkar","year":"2016"},{"key":"10.1016\/j.ejphar.2024.176929_bib46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantitative measurement of motor inco-ordination in naive mice using an accelerating rotarod","volume":"20","author":"Jones","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib47","doi-asserted-by":"crossref","DOI":"10.29046\/JJP.012.1.001","article-title":"The serotonin theory of depression","volume":"12","author":"Kerr","year":"1994","journal-title":"Jefferson Journal of Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176929_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot102269","article-title":"Bradford assay for determining protein concentration","volume":"2020","author":"Kielkopf","year":"2020","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ejphar.2024.176929_bib49","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10571-017-0510-4","article-title":"BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity","volume":"38","author":"Kowia\u0144ski","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2024.176929_bib50","first-page":"254","article-title":"Review of intraperitoneal injection of sodium pentobarbital as a method of euthanasia in laboratory rodents","volume":"59","author":"Laferriere","year":"2020","journal-title":"JAALAS"},{"key":"10.1016\/j.ejphar.2024.176929_bib51","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1016\/S0924-977X(12)70372-3","article-title":"P.2.b.015 Electrophysiological effects of the multimodal antidepressant Lu AA21004 on serotonin transmission in the rat hippocampus","volume":"22","author":"Lecours","year":"2012","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2024.176929_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/neu.2016.69","article-title":"Inflammation and depression: a causal or coincidental link to the pathophysiology?","volume":"30","author":"Leonard","year":"2018","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.ejphar.2024.176929_bib53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/08830185.2014.933957","article-title":"mTOR signaling in T cell immunity and autoimmunity","volume":"34","author":"Liu","year":"2015","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2024.176929_bib54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/157015911796557911","article-title":"Multiple sclerosis: pathogenesis and treatment","volume":"9","author":"Loma","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib55","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-2826.2002.00861.x","article-title":"Functional subsets of serotonergic neurones: implications for control of the hypothalamic\u2010pituitary\u2010adrenal Axis","volume":"14","author":"Lowry","year":"2002","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2024.176929_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2018.06.007","article-title":"Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats","volume":"142","author":"Lu","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2024.176929_bib57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1741-7015-10-66","article-title":"Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways","volume":"10","author":"Maes","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.ejphar.2024.176929_bib58","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176929_bib59","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.18632\/oncotarget.23862","article-title":"Preclinical evaluation of the PI3K\/Akt\/mTOR pathway in animal models of multiple sclerosis","volume":"9","author":"Mammana","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2024.176929_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.824831","article-title":"Effectiveness of vortioxetine in patients with major depressive disorder in real-world clinical practice: results of the RELIEVE study","volume":"13","author":"Mattingly","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.ejphar.2024.176929_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1583","article-title":"Neurodegeneration in multiple sclerosis","volume":"15","author":"Mey","year":"2023","journal-title":"WIREs Mechanisms of Disease"},{"key":"10.1016\/j.ejphar.2024.176929_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.dhjo.2014.07.002","article-title":"Social participation and health-related quality of life in people with multiple sclerosis","volume":"8","author":"Mikula","year":"2015","journal-title":"Disabil Health J"},{"key":"10.1016\/j.ejphar.2024.176929_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109571","article-title":"Neuroprotective effect of secukinumab against rotenone induced Parkinson's disease in rat model: involvement of IL-17, HMGB-1\/TLR4 axis and BDNF\/TrKB cascade","volume":"114","author":"Mohamed","year":"2023","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2024.176929_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.740966","article-title":"Inhibition of brain GTP cyclohydrolase I attenuates 3-nitropropionic acid-induced striatal toxicity: involvement of mas receptor\/PI3k\/akt\/CREB\/BDNF Axis","volume":"12","author":"Mustafa","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111387","article-title":"Nicorandil and carvedilol mitigates motor deficits in experimental autoimmune encephalomyelitis-induced multiple sclerosis: role of TLR4\/TRAF6\/MAPK\/NF-\u03baB signalling cascade","volume":"127","author":"Mustafa","year":"2024","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2024.176929_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108977","article-title":"Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation","volume":"208","author":"Nemutlu Samur","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.176929_bib67","doi-asserted-by":"crossref","DOI":"10.20517\/2347-8659.2020.25","article-title":"What is the role of Brain derived neurotrophic factor in Multiple Sclerosis neuroinflammation?","author":"Nociti","year":"2020","journal-title":"Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2024.176929_bib68","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0889-1591(02)00010-7","article-title":"Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of \u2018depression due to multiple sclerosis\u02bc","volume":"16","author":"Pollak","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2024.176929_bib69","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2015.03.042","article-title":"Animal models of multiple sclerosis","volume":"759","author":"Procaccini","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2004.04.029","article-title":"The role of the 5-HT1D receptor as a presynaptic autoreceptor in the Guinea pig","volume":"493","author":"Pullar","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110957","article-title":"Activation of alpha-7 nicotinic acetylcholine receptor by tropisetron mitigates 3-nitropropionic acid-induced Huntington's disease in rats: role of PI3K\/Akt and JAK2\/NF-\u03baB signaling pathways","volume":"393","author":"Rabie","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2024.176929_bib72","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bcp.2018.01.047","article-title":"Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor\/PI3K\/Akt\/BDNF pathway and inhibition of angiotensin II type-1 receptor\/NF-\u03baB axis","volume":"151","author":"Rabie","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib73","article-title":"Adenosine A1 receptor agonist, N6-cyclohexyladenosine, attenuates Huntington's disease via stimulation of TrKB\/PI3K\/Akt\/CREB\/BDNF pathway in 3-nitropropionic acid rat model","volume":"369","author":"Rabie","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2024.176929_bib74","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","article-title":"The role of PI3K\/Akt and ERK in neurodegenerative disorders","volume":"35","author":"Rai","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2024.176929_bib75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/eji.202149589","article-title":"Sex differences regulate immune responses in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"52","author":"Ryan","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2024.176929_bib76","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/medicina55060232","article-title":"Early clinical features, time to secondary progression, and disability milestones in polish multiple sclerosis patients","volume":"55","author":"Rzepi\u0144ski","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.ejphar.2024.176929_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109647","article-title":"Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: involvement of the PI3K\/Akt\/GSK-3\u03b2 pathway","volume":"115","author":"Sadek","year":"2023","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2024.176929_bib78","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-023-01399-3","article-title":"Neuroprotective effect of curcumin against experimental autoimmune encephalomyelitis-induced cognitive and physical impairments in mice: an insight into the role of the AMPK\/SIRT1 pathway","author":"Sadek","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2024.176929_bib79","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(91)90284-3","article-title":"Effects of 5-hydroxytryptophan on extracellular serotonin in the spinal cord of rats with experimental allergic encephalomyelitis","volume":"559","author":"Samathanam","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2024.176929_bib80","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.11293","article-title":"Multiple sclerosis and serotonin: potential therapeutic applications","author":"San Hernandez","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2024.176929_bib81","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.3390\/ijms19123725","article-title":"PI3K signaling in neurons: a central node for the control of multiple functions","volume":"19","author":"S\u00e1nchez-Alegr\u00eda","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176929_bib82","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3390\/brainsci12111466","article-title":"Vortioxetine improves depressive symptoms and cognition in Parkinson's disease patients with major depression: an open-label prospective study","volume":"12","author":"Santos Garc\u00eda","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejphar.2024.176929_bib83","first-page":"249","author":"Savitz","year":"2016","journal-title":"Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders"},{"key":"10.1016\/j.ejphar.2024.176929_bib84","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s13311-019-00805-5","article-title":"Vildagliptin attenuates huntington's disease through activation of GLP-1 receptor\/PI3K\/Akt\/BDNF pathway in 3-nitropropionic acid rat model","volume":"17","author":"Sayed","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2024.176929_bib85","doi-asserted-by":"crossref","DOI":"10.3791\/52434-v","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","author":"Seibenhener","year":"2015","journal-title":"JoVE"},{"key":"10.1016\/j.ejphar.2024.176929_bib86","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jnnp.2004.054635","article-title":"Depression in multiple sclerosis: a review","volume":"76","author":"Siegert","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176929_bib87","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1098\/rstb.1999.0510","article-title":"The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease","volume":"354","author":"Smith","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ejphar.2024.176929_bib88","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.pharep.2017.01.030","article-title":"Vortioxetine: a review of the pharmacology and clinical profile of the novel antidepressant","volume":"69","author":"Sowa-Ku\u0107ma","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2024.176929_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.677879","article-title":"Antidepressants on multiple sclerosis: a review of in vitro and in vivo models","volume":"12","author":"Stamoula","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2024.176929_bib90","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bph.14074","article-title":"Vortioxetine exerts anti\u2010inflammatory and immunomodulatory effects on human monocytes\/macrophages","volume":"175","author":"Talmon","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176929_bib91","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","article-title":"Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism","volume":"20","author":"Tao","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2024.176929_bib92","article-title":"Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines","volume":"9","author":"Tauil","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.ejphar.2024.176929_bib93","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00213-023-06445-0","article-title":"The beneficial effects of vortioxetine on BDNF, CREB, S100B, \u03b2 amyloid, and glutamate NR2b receptors in chronic unpredictable mild stress model of depression","volume":"240","author":"\u00dcnal","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2024.176929_bib94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2024.176929_bib95","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The Open-Field Test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.ejphar.2024.176929_bib96","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Multiple Sclerosis Journal"},{"key":"10.1016\/j.ejphar.2024.176929_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00255","article-title":"cAMP response element-binding protein (CREB): a possible signaling molecule link in the pathophysiology of schizophrenia","volume":"11","author":"Wang","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176929_bib98","first-page":"47","article-title":"In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets","volume":"5","author":"Westrich","year":"2012","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.ejphar.2024.176929_bib100","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1242\/dev.137075","article-title":"Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination","volume":"143","author":"Yu","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.ejphar.2024.176929_bib101","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4103\/1673-5374.237109","article-title":"Role of nuclear factor \u03baB in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"13","author":"Yue","year":"2018","journal-title":"Neural Regen Res"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924006186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924006186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T19:05:06Z","timestamp":1726254306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924006186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":100,"alternative-id":["S0014299924006186"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176929","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vortioxetine ameliorates experimental autoimmune encephalomyelitis model of multiple sclerosis in mice via activation of PI3K\/Akt\/CREB\/BDNF cascade and modulation of serotonergic pathway signaling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"176929"}}